Publicacións en colaboración con investigadores/as de Hospital General de Castellón (29)

2024

  1. Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement — A Multicenter Cross-Sectional CLINI-AEDV Study

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 1, pp. 36-47

2023

  1. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91

  2. Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated with Internal Fistulizing Disease: BIOSCOPE Study from GETECCU

    American Journal of Gastroenterology, Vol. 118, Núm. 6, pp. 1036-1046

  3. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

2022

  1. Higher Adherence to ERAS Society® Recommendations is Associated with Shorter Hospital Stay Without an Increase in Postoperative Complications or Readmissions in Bariatric Surgery: the Association Between Use of Enhanced Recovery After Surgery Protocols and Postoperative Complications after Bariatric Surgery (POWER 3) Multicenter Observational Study

    Obesity surgery, Vol. 32, Núm. 4, pp. 1289-1299

  2. Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network

    European Journal of Pediatrics, Vol. 181, Núm. 2, pp. 789-799

2021

  1. Characterization of COPD admissions during the first COVID-19 outbreak

    International Journal of COPD, Vol. 16, pp. 1549-1554

  2. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  3. Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study

    Transplantation and Cellular Therapy, Vol. 27, Núm. 4, pp. 311.e1-311.e10

  4. Mapping the clinical pharmacokinetics and pharmacogenetic units operating in Spanish hospitals

    Farmacia Hospitalaria, Vol. 45, pp. 102-108

  5. Therapeutic drug monitoring of voriconazole: Validation of a high performance liquid chromatography method and comparison with an ARK immunoassay

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 3, pp. 154-159

2020

  1. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Hospital treatment of moderate-severe bronchiolitis, hypertonic or physiological saline? Analysis of risk factors associated with readmission

    Pediatria de Atencion Primaria, Vol. 21, Núm. 82, pp. e31-e40

  2. Multicentric study on total pancreatectomies

    Cirugia Espanola, Vol. 97, Núm. 7, pp. 377-384

2017

  1. Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study

    HIV Medicine, Vol. 18, Núm. 7, pp. 482-489

2016

  1. An assessment of the management of spasticity in Spain: The 5E study

    Revista de Neurologia, Vol. 63, Núm. 7, pp. 289-296

  2. Potential risk for inappropriate dyslipidemia screening in Primary Care in Spain

    Revista del Laboratorio Clinico, Vol. 9, Núm. 2, pp. 48-53

  3. Request of thyroid function tests from Primary Care in Spain

    Endocrinologia y Nutricion, Vol. 63, Núm. 1, pp. 19-26

2015

  1. Manejo de la sedación y la analgesia en unidades de cuidados intensivos neonatales españolas

    Anales de Pediatria, Vol. 83, Núm. 2, pp. 75-84

  2. Potential over request in anemia laboratory tests in primary care in Spain

    Hematology, Vol. 20, Núm. 6, pp. 368-373